2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Conditions
Breast Neoplasms
2936
Neoplasms
2634
Lung Neoplasms
1371
Colorectal Neoplasms
1332
Prostatic Neoplasms
1216
Carcinoma, Non-Small-Cell Lung
1080
Carcinoma, Hepatocellular
784
Stomach Neoplasms
721
Pancreatic Neoplasms
704
Ovarian Neoplasms
586
Colonic Neoplasms
534
Uterine Cervical Neoplasms
497
Head and Neck Neoplasms
496
Rectal Neoplasms
472
Melanoma
467
Multiple Myeloma
463
Esophageal Neoplasms
423
Neoplasm Metastasis
418
Brain Neoplasms
405
Lymphoma
399
Precursor Cell Lymphoblastic Leukemia-Lymphoma
398
Urinary Bladder Neoplasms
387
Leukemia, Myeloid, Acute
387
Leukemia
339
Carcinoma, Renal Cell
329
Liver Neoplasms
320
Endometrial Neoplasms
319
Hematologic Neoplasms
313
Recurrence
298
Disease
275
Interventions
anlotinib
1
Angiogenesis Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Stereotactic Body Radiation Therapy
×
Clear all
NCT04912128
2021-06-03
AnloSBRT
Peking University Third Hospital
Completed
30 enrolled